- Home
- CLDX vs AMRC Comparison
CLDX vs AMRC Comparison
Compare CLDX & AMRC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CLDX
- AMRC
- Stock Information
- Founded
- CLDX 1983
- AMRC 2000
- Country
- CLDX United States
- AMRC United States
- Employees
- CLDX N/A
- AMRC N/A
- Industry
- CLDX Biotechnology: In Vitro & In Vivo Diagnostic Substances
- AMRC Engineering & Construction
- Sector
- CLDX Health Care
- AMRC Consumer Discretionary
- Exchange
- CLDX Nasdaq
- AMRC Nasdaq
- Market Cap
- CLDX 1.8B
- AMRC 1.5B
- IPO Year
- CLDX 2008
- AMRC 2010
- Fundamental
- Price
- CLDX $25.77
- AMRC $24.60
- Analyst Decision
- CLDX Buy
- AMRC Strong Buy
- Analyst Count
- CLDX 8
- AMRC 10
- Target Price
- CLDX $64.83
- AMRC $36.88
- AVG Volume (30 Days)
- CLDX 992.8K
- AMRC 291.1K
- Earning Date
- CLDX 11-06-2024
- AMRC 11-07-2024
- Dividend Yield
- CLDX N/A
- AMRC N/A
- EPS Growth
- CLDX N/A
- AMRC 13.70
- EPS
- CLDX N/A
- AMRC 1.00
- Revenue
- CLDX $9,976,000.00
- AMRC $1,678,629,000.00
- Revenue This Year
- CLDX N/A
- AMRC $30.87
- Revenue Next Year
- CLDX N/A
- AMRC $11.01
- P/E Ratio
- CLDX N/A
- AMRC $23.83
- Revenue Growth
- CLDX 128.55
- AMRC 32.70
- 52 Week Low
- CLDX $22.93
- AMRC $17.55
- 52 Week High
- CLDX $53.18
- AMRC $39.68
- Technical
- Relative Strength Index (RSI)
- CLDX 45.64
- AMRC 36.03
- Support Level
- CLDX $24.48
- AMRC $23.75
- Resistance Level
- CLDX $26.66
- AMRC $28.65
- Average True Range (ATR)
- CLDX 1.19
- AMRC 1.13
- MACD
- CLDX 0.03
- AMRC -0.19
- Stochastic Oscillator
- CLDX 35.73
- AMRC 9.28
About CLDX Celldex Therapeutics Inc.
Celldex Therapeutics Inc is a biopharmaceutical company. It is focused on the development and commercialization of several immunotherapy technologies and other cancer-targeting biologics. The company is also engaged in clinical trials for products targeting breast cancer, metastatic melanoma, lung cancer, solid tumors, and ovarian cancer. Its pipeline products are Varlilumab, CDX-301, CDX-1140,CDX-0159/Anti-KIT Program, and CDX-527.
About AMRC Ameresco Inc.
Ameresco Inc provides energy efficiency solutions for facilities in North America and Europe. It focuses on projects that reduce energy, also focuses on the operations and maintenance costs of governmental, educational, utility, healthcare, and other institutional, commercial, and industrial entities facilities. Ameresco distributes solar energy products and systems, such as PV panels, solar regulators, solar charge controllers, inverters, solar-powered lighting systems, solar-powered water pumps, solar panel mounting hardware, and other system components. The company's segment includes U.S. Regions; U.S. Federal; Canada; Alternative Fuels; Non-Solar DG and All Other. It derives a majority of revenue from the U.S. Regions segment.